A Study to Evaluate the Efficacy and Safety of TAK-906 in Adult Participants With Symptomatic Idiopathic or Diabetic Gastroparesis
Clinical trial NCT03544229 · COMPLETED
Trial details
- NCT number
- NCT03544229
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-14
- Primary completion
- 2021-06-14
- Enrollment
- 242
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.